HIV-Gag (AA 2-132) Antikörper (FITC)
Kurzübersicht für HIV-Gag (AA 2-132) Antikörper (FITC) (ABIN7156067)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2-132
-
Verwendungszweck
- gag Antibody, FITC conjugated
-
Aufreinigung
- Protein G purified
-
Reinheit
- >95 %
-
Immunogen
- Recombinant Human immunodeficiency virus type 1 group M subtype B Gag polyprotein protein (2-132AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- HIV-Gag
-
Andere Bezeichnung
- HIV gag
-
Substanzklasse
- Viral Protein
-
Hintergrund
-
Background: Gag polyprotein: Mediates, with Gag-Pol polyrotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi).1 Publication Matrix protein p17: Targets the polyprotein to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus (By similarity). Matrix protein is part of the pre-integration complex. Implicated in the release from host cell mediated by Vpu. Binds to RNA (By similarity).
Aliases: gag antibody, Gag polyprotein antibody, Pr55Gag) [Cleaved into: Matrix protein p17 antibody, MA), Capsid protein p24 antibody, CA), Spacer peptide 1 antibody, SP1 antibody, p2), Nucleocapsid protein p7 antibody, NC), Spacer peptide 2 antibody, SP2 antibody, p1), p6-gag] antibody
-
UniProt
- P04591
Target
-
